Clinical Trial Update: Real World Outcomes of Intranasal MuSE Exosomes and Stem Cells in Neurological Regenerative Therapy

View source ↗

Summary

An update on an ongoing real-world study of intranasal MuSE exosomes and stem cells for neurological regenerative therapy, with enrollment by invitation across …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Autism Spectrum Disorder
• Cerebral Palsy
• Hypoxic-ischemic Encephalopathy
• Multiple Sclerosis
• Parkinson Disease
• Stroke
• Traumatic Brain Injury

Drugs mentioned

• Intranasal Stem Cell Therapy (intranasal stem cell preparation)
• MuSE Exosomes (exosome-based therapy)

Snippet

Sponsor: Healing Hope International | Conditions: Traumatic Brain Injury, Cerebral Palsy | Status: ENROLLING_BY_INVITATION